This First Word report examines key future events in the biosimilars market. It includes data from extensive secondary research plus the most prominent insights gained from in-depth telephone interviews with 12 biosimilar experts, questionnaires completed by 22 industry experts vetted for their biosimilar market knowledge, discussions with commercial, legal and financial experts, and biosimilar conference proceedings. Available for purchase here. (Source: FirstWord, May 2014).
You are here: / / The Future Of Biosimilars: Mapping Critical Uncertainties And The Impact Of Future Events